Condensed Consolidated Statements of Changes in Redeemable Convertible Preferred Shares and in Stockholders’ Equity (Capital Deficiency) (Unaudited) (Parentheticals) - USD ($) $ in Thousands |
3 Months Ended | |||
|---|---|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|||
| Issuance of common stock under open market sales agreement, net of issuance costs | [1] | $ 1 | ||
| Issuance of Common Stock and warrants under Private Investment in Public Equity (“PIPE”), net of issuance costs | [1] | $ 1 | ||
| Common Stock | ||||
| Issuance of common stock under open market sales agreement, net of issuance costs | [1] | $ 176 | ||
| Issuance of Common Stock and warrants under Private Investment in Public Equity (“PIPE”), net of issuance costs | [1] | $ 176 | ||
| ||||
| X | ||||||||||
- Definition The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|